Supplementary Tables from The Heme-Regulated Inhibitor Pathway Modulates Susceptibility of Poor Prognosis B-Lineage Acute Leukemia to BH3-Mimetics
Kaitlyn H. Smith(University of North Dakota), Joseph T. Opferman(St. Jude Children's Research Hospital), Amit Budhraja(St. Jude Children's Research Hospital), Jon P. Connelly(St. Jude Children's Research Hospital), John C. Panetta(St. Jude Children's Research Hospital), Kathryn G. Roberts(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), John D. Schuetz(St. Jude Children's Research Hospital), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), Meghan E. Turnis(St. Jude Children's Research Hospital), John Lynch(University of California, San Francisco)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k